45.[20221004]The Role of Fc Gamma Receptors in AMR of Kidney Transplan…
페이지 정보
작성자 신호식 작성일23-02-03 13:35 조회482회 댓글0건관련링크
-
https://youtu.be/BF3svDPEcso
462회 연결
https://youtu.be/BF3svDPEcso
본문
첨부한 자료(유튜브 클립, 참고문헌 등)를 학문적 목적으로만 사용해 주시길 부탁드립니다
Review Transpl Int
. 2022 Jul 20;35:10465. doi: 10.3389/ti.2022.10465. eCollection 2022.
The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
Boris Delpire 1 2, Elisabet Van Loon 1 2 3, Maarten Naesens 1 2 3
Affiliations expand
PMID: 35935272 PMCID: PMC9346079 DOI: 10.3389/ti.2022.10465
Free PMC article
Abstract
For the past decades, complement activation and complement-mediated destruction of allograft cells were considered to play a central role in anti-HLA antibody-mediated rejection (AMR) of kidney transplants. However, also complement-independent mechanisms are relevant in the downstream immune activation induced by donor-specific antibodies, such as Fc-gamma receptor (FcγR)-mediated direct cellular activation. This article reviews the literature regarding FcγR involvement in AMR, and the potential contribution of FcγR gene polymorphisms to the risk for antibody mediated rejection of kidney transplants. There is large heterogeneity between the studies, both in the definition of the clinical phenotypes and in the technical aspects. The study populations were generally quite small, except for two larger study cohorts, which obviates drawing firm conclusions regarding the associations between AMR and specific FcγR polymorphisms. Although FcγR are central in the pathophysiology of AMR, it remains difficult to identify genetic risk factors for AMR in the recipient's genome, independent of clinical risk factors, independent of the donor-recipient genetic mismatch, and in the presence of powerful immunosuppressive agents. There is a need for larger, multi-center studies with standardised methods and endpoints to identify potentially relevant FcγR gene polymorphisms that represent an increased risk for AMR after kidney transplantation.
Review Transpl Int
. 2022 Jul 20;35:10465. doi: 10.3389/ti.2022.10465. eCollection 2022.
The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
Boris Delpire 1 2, Elisabet Van Loon 1 2 3, Maarten Naesens 1 2 3
Affiliations expand
PMID: 35935272 PMCID: PMC9346079 DOI: 10.3389/ti.2022.10465
Free PMC article
Abstract
For the past decades, complement activation and complement-mediated destruction of allograft cells were considered to play a central role in anti-HLA antibody-mediated rejection (AMR) of kidney transplants. However, also complement-independent mechanisms are relevant in the downstream immune activation induced by donor-specific antibodies, such as Fc-gamma receptor (FcγR)-mediated direct cellular activation. This article reviews the literature regarding FcγR involvement in AMR, and the potential contribution of FcγR gene polymorphisms to the risk for antibody mediated rejection of kidney transplants. There is large heterogeneity between the studies, both in the definition of the clinical phenotypes and in the technical aspects. The study populations were generally quite small, except for two larger study cohorts, which obviates drawing firm conclusions regarding the associations between AMR and specific FcγR polymorphisms. Although FcγR are central in the pathophysiology of AMR, it remains difficult to identify genetic risk factors for AMR in the recipient's genome, independent of clinical risk factors, independent of the donor-recipient genetic mismatch, and in the presence of powerful immunosuppressive agents. There is a need for larger, multi-center studies with standardised methods and endpoints to identify potentially relevant FcγR gene polymorphisms that represent an increased risk for AMR after kidney transplantation.
